Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS, has been elected as the Academic representative for Europe and Africa on the International Society of Pharmaco-Epidemiology Board of Directors.

Horizontal portrait of Dani Prieto-Alhambra

Dani leads Pharmaco- and Device Epidemiology research at NDORMS and is currently investigating the use, safety, and effectiveness of COVID-19 therapies and vaccines.

On being elected to the Board, Dani said "Being elected as the Academic representative for Europe/Africa is a great opportunity and a responsibility. Setting the standards for research into the safety of medicines and vaccines is more important now than ever. I will be delighted to represent the values of academia in the BoD to make sure ISPE continues to be a welcoming, inclusive society that strives to improve the quality and methodological standards of pharmacoepidemiology globally."

ISPE is a large international scientific society that sets the basis for methodological and clinical research into the use and the effects of medicines in routine practice settings. The ISPE Board of Directors decides on all aspects related to the management and planning of ISPE's activities.

Similar stories

Doctor Ghada Alsaleh awarded a Versus Arthritis Career Development Fellowship

Postdoctoral Researcher Ghada Alsaleh has been awarded a research grant by Versus Arthritis which she will use to develop a new therapy for osteoarthritis.

Study finds marked differences in the use of ankle replacements across six countries

A new study published in Foot and Ankle International reviews the use of ankle replacements across 6 countries to predict why there is a variance in their use, and to determine how far current demands are being met.

NDORMS wins government funding to develop AI for bone health

A state-of-the-art method that uses artificial intelligence to check bone health and reduce fracture risk has been successful in the latest round of the Artificial Intelligence in Health and Care Award.

COVID-19 vaccine safety monitoring should account for age, gender, and database differences

The largest, most extensive global network study on background rates for adverse events of special interest identifies important age, sex and database differences that should inform future safety surveillance efforts.

Professor Keith Willett recognised in Queen’s Birthday Honours

Professor of Orthopaedic Trauma Surgery at NDORMS, Keith Willett becomes a Knight Bachelor for services to the NHS.

New research from the Kennedy Institute of Rheumatology identifies a role for CD200 in limiting atherosclerosis

A new study published in Circulation Research shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.